Cargando…

1269. Infection, Clinical Syndromes and Antimicrobial Resistance by Aeromonas species: 13-Year Experience with an Emerging Pathogen at a Tertiary Care Center

BACKGROUND: Aeromonas spp. are emerging pathogens that cause a wide breadth of clinical syndromes, ranging from acute gastroenteritis to skin and soft tissue infections, sepsis, and “flesh-eating” necrotizing fasciitis. Aeromonads have been associated with natural disasters and have predominance in...

Descripción completa

Detalles Bibliográficos
Autores principales: Pineda-Reyes, Roberto, Orndorff, Joseph, Reynoso, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644731/
http://dx.doi.org/10.1093/ofid/ofab466.1461
_version_ 1784610153449914368
author Pineda-Reyes, Roberto
Orndorff, Joseph
Reynoso, David
author_facet Pineda-Reyes, Roberto
Orndorff, Joseph
Reynoso, David
author_sort Pineda-Reyes, Roberto
collection PubMed
description BACKGROUND: Aeromonas spp. are emerging pathogens that cause a wide breadth of clinical syndromes, ranging from acute gastroenteritis to skin and soft tissue infections, sepsis, and “flesh-eating” necrotizing fasciitis. Aeromonads have been associated with natural disasters and have predominance in estuarine ecosystems, generating a negative impact on the fishing industry and aquaculture, as well as morbidity and mortality in human populations at risk. Antimicrobial resistance patterns differ by geographic locations worldwide, and studies to guide the therapy in the era of multidrug resistance are lacking in the US. METHODS: A retrospective case series was designed to chart review all adult subjects who had culture proven Aeromonas spp. infections during the period 2008-2020. Demographic data, water exposure, clinical syndromes on presentation, origin (community-acquired vs. nosocomial) and severity of infection, antibiograms, empirical antibiotics, time-to-appropriate therapy, and treatment outcomes were collected. RESULTS: Eighty-two subjects were included in the analysis. Demographic and clinical data is summarized in Table 1. Near 20% individuals had water exposure, including 53% of those with traumatic wound infections. Skin and soft tissue infection (including traumatic and surgical wound infections) was the most frequent clinical syndrome (51.2%). Sepsis was present on admission in 33% inpatients. Appropriate antibiotics were instituted in a median of 2 days (IQR=1-5), and the most prescribed empiric agents were piperacillin-tazobactam (48%) and meropenem (13.3%). Most isolates were susceptible to cefepime (70/71, 98.6%), levofloxacin (72/78, 92.3%) and TMP-SMX (69/78, 88.5%). Resistance to meropenem was reported in 18/31 isolates (58.1%) after 2015. Treatment failure was identified in 32.3% cases. [Image: see text] Most cases (55%) were encountered during the months of spring and summer, which have warmer temperatures and seasonal heavy rains. Tropical storms caused significant flooding in the Galveston Bay area and Southeast Texas during the summer of 2015, which interestingly coincides with the high number of cases. However, following Hurricane Ike in 2008 or Hurricane Harvey in 2017, the number of cases did not significantly increase. [Image: see text] CONCLUSION: Aeromonads are emerging pathogens that cause mainly intraabdominal and skin and soft tissue infections. Their incidence is seasonal (55% cases in spring and summer) and it is associated with water exposure in more than half of those with traumatic wound infections. In subjects with specific risk factors, the use of carbapenem-sparing strategies, such as 3(rd) or 4(th) generation cephalosporins, fluoroquinolones or TMP-SMX, may improve outcomes. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8644731
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86447312021-12-06 1269. Infection, Clinical Syndromes and Antimicrobial Resistance by Aeromonas species: 13-Year Experience with an Emerging Pathogen at a Tertiary Care Center Pineda-Reyes, Roberto Orndorff, Joseph Reynoso, David Open Forum Infect Dis Poster Abstracts BACKGROUND: Aeromonas spp. are emerging pathogens that cause a wide breadth of clinical syndromes, ranging from acute gastroenteritis to skin and soft tissue infections, sepsis, and “flesh-eating” necrotizing fasciitis. Aeromonads have been associated with natural disasters and have predominance in estuarine ecosystems, generating a negative impact on the fishing industry and aquaculture, as well as morbidity and mortality in human populations at risk. Antimicrobial resistance patterns differ by geographic locations worldwide, and studies to guide the therapy in the era of multidrug resistance are lacking in the US. METHODS: A retrospective case series was designed to chart review all adult subjects who had culture proven Aeromonas spp. infections during the period 2008-2020. Demographic data, water exposure, clinical syndromes on presentation, origin (community-acquired vs. nosocomial) and severity of infection, antibiograms, empirical antibiotics, time-to-appropriate therapy, and treatment outcomes were collected. RESULTS: Eighty-two subjects were included in the analysis. Demographic and clinical data is summarized in Table 1. Near 20% individuals had water exposure, including 53% of those with traumatic wound infections. Skin and soft tissue infection (including traumatic and surgical wound infections) was the most frequent clinical syndrome (51.2%). Sepsis was present on admission in 33% inpatients. Appropriate antibiotics were instituted in a median of 2 days (IQR=1-5), and the most prescribed empiric agents were piperacillin-tazobactam (48%) and meropenem (13.3%). Most isolates were susceptible to cefepime (70/71, 98.6%), levofloxacin (72/78, 92.3%) and TMP-SMX (69/78, 88.5%). Resistance to meropenem was reported in 18/31 isolates (58.1%) after 2015. Treatment failure was identified in 32.3% cases. [Image: see text] Most cases (55%) were encountered during the months of spring and summer, which have warmer temperatures and seasonal heavy rains. Tropical storms caused significant flooding in the Galveston Bay area and Southeast Texas during the summer of 2015, which interestingly coincides with the high number of cases. However, following Hurricane Ike in 2008 or Hurricane Harvey in 2017, the number of cases did not significantly increase. [Image: see text] CONCLUSION: Aeromonads are emerging pathogens that cause mainly intraabdominal and skin and soft tissue infections. Their incidence is seasonal (55% cases in spring and summer) and it is associated with water exposure in more than half of those with traumatic wound infections. In subjects with specific risk factors, the use of carbapenem-sparing strategies, such as 3(rd) or 4(th) generation cephalosporins, fluoroquinolones or TMP-SMX, may improve outcomes. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644731/ http://dx.doi.org/10.1093/ofid/ofab466.1461 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Pineda-Reyes, Roberto
Orndorff, Joseph
Reynoso, David
1269. Infection, Clinical Syndromes and Antimicrobial Resistance by Aeromonas species: 13-Year Experience with an Emerging Pathogen at a Tertiary Care Center
title 1269. Infection, Clinical Syndromes and Antimicrobial Resistance by Aeromonas species: 13-Year Experience with an Emerging Pathogen at a Tertiary Care Center
title_full 1269. Infection, Clinical Syndromes and Antimicrobial Resistance by Aeromonas species: 13-Year Experience with an Emerging Pathogen at a Tertiary Care Center
title_fullStr 1269. Infection, Clinical Syndromes and Antimicrobial Resistance by Aeromonas species: 13-Year Experience with an Emerging Pathogen at a Tertiary Care Center
title_full_unstemmed 1269. Infection, Clinical Syndromes and Antimicrobial Resistance by Aeromonas species: 13-Year Experience with an Emerging Pathogen at a Tertiary Care Center
title_short 1269. Infection, Clinical Syndromes and Antimicrobial Resistance by Aeromonas species: 13-Year Experience with an Emerging Pathogen at a Tertiary Care Center
title_sort 1269. infection, clinical syndromes and antimicrobial resistance by aeromonas species: 13-year experience with an emerging pathogen at a tertiary care center
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644731/
http://dx.doi.org/10.1093/ofid/ofab466.1461
work_keys_str_mv AT pinedareyesroberto 1269infectionclinicalsyndromesandantimicrobialresistancebyaeromonasspecies13yearexperiencewithanemergingpathogenatatertiarycarecenter
AT orndorffjoseph 1269infectionclinicalsyndromesandantimicrobialresistancebyaeromonasspecies13yearexperiencewithanemergingpathogenatatertiarycarecenter
AT reynosodavid 1269infectionclinicalsyndromesandantimicrobialresistancebyaeromonasspecies13yearexperiencewithanemergingpathogenatatertiarycarecenter